Dermatology

Thoracic Malignancies

Questions discussed in this category

How would you manage a patient with stage IV EGFR L858R mutation but with a debilitating drug rash from osimertinib?

Should we switch to a new TKI?

1 Answer available

Do you utilize a constraint for skin/dermatitis in setting of thoracic chemoradiation?

When tumors come close to chest wall, how do you define skin contour?

1 Answer available

Would you still consider durvalumab consolidation after definitive chemoradiation for patients with Stage III NSCLC who are on stable weekly methotrexate dosing for psoriasis/psoriatic arthritis?

1 Answer available

Papers discussed in this category

J Immunother Cancer,

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.

Current oncology (Toronto, Ont.), 2015 Apr

Management of egfr tki-induced dermatologic adverse events.

Related Topics in Dermatology